5EIS

FIRST DOMAIN OF HUMAN BROMODOMAIN BRD4 IN COMPLEX WITH INHIBITOR 3-(4-Chlorobenzyl)-7-ethyl-3,7-dihydropurine-2,6-dione

Functional Information from PDB Data

site_id	AC1
Number of Residues	9
Details	binding site for residue 5OU A 201

Chain	Residue
A	PRO53
A	TRP81
A	PRO82
A	PHE83
A	VAL87
A	LEU92
A	ASN140
A	MET149
A	HOH308

---

site_id	AC2
Number of Residues	6
Details	binding site for residue EDO A 202

Chain	Residue
A	ILE100
A	ILE101
A	LYS102
A	THR103
A	ASN135
A	HOH301

---

site_id	AC3
Number of Residues	5
Details	binding site for residue EDO A 203

Chain	Residue
A	LYS57
A	ASN116
A	ASN117
A	ASP144
A	ASP145

---

Functional Information from PROSITE/UniProt

site_id	PS00633
Number of Residues	60
Details	BROMODOMAIN_1 Bromodomain signature. AwpFqqpvDavklnlpDYYkiIktpMdmgtIkkrlenny..Ywnaqeciqdfnt.MftNCyiY

Chain	Residue	Details
A	ALA80-TYR139

---

Functional Information from SwissProt/UniProt

site_id	SWS_FT_FI1
Number of Residues	1
Details	SITE: Acetylated histone binding => ECO:0000269|PubMed:22464331

Chain	Residue	Details
A	ASN140

---

site_id	SWS_FT_FI2
Number of Residues	2
Details	CROSSLNK: Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2) => ECO:0007744|PubMed:28112733

Chain	Residue	Details
A	LYS99

---